title: Octreotide acetate administration for malignant bowel obstruction induces severe bradycardia in patients with terminal stage cancer: two case reports.
authors.forename: Kazuko
authors.initials: K
authors.lastname: Kubota
authors.forename: Yoko
authors.initials: Y
authors.lastname: Hasumi
authors.forename: Aya
authors.initials: A
authors.lastname: Numata
authors.forename: Takehiro
authors.initials: T
authors.lastname: Tukazaki
authors.forename: Koji
authors.initials: K
authors.lastname: Horie
authors.forename: Kouiti
authors.initials: K
authors.lastname: Hashimoto
authors.forename: Harushige
authors.initials: H
authors.lastname: Yokota
mesh_terms: D000328:Adult; D001919:Bradycardia / Q000139:chemically induced*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects*; D012720:Severity of Illness Index; D013727:Terminal Care; D002583:Uterine Cervical Neoplasms / Q000150:complications*
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide